| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/03/2005 | CA2534941A1 Chemokine inhibiting piperazine derivatives and their use to treat myocarditis |
| 03/02/2005 | EP1510519A1 Pharmaceutical compositions comprising 2,3-diarylpyrazolo[1,5-B]pyridazine derivatives |
| 03/02/2005 | EP1510515A1 Phenylglycine derivatives as serine protease inhibitors |
| 03/02/2005 | EP1510223A1 Intravenous composition, process for producing the same and preparation thereof |
| 03/02/2005 | EP1510221A1 Preventives and/or remedies for subjects with the expression or activation of her2 and/or egfr |
| 03/02/2005 | EP1510220A1 Therapeutic inhibitor of vascular smooth muscle cells |
| 03/02/2005 | EP1510218A1 Extract of plant dendrobii caulis and preparing process thereof |
| 03/02/2005 | EP1510208A1 Pharmaceutical composition comprising a combination of metformin and statin |
| 03/02/2005 | EP1510137A1 Pyruvate enriched onion extract |
| 03/02/2005 | EP1509772A2 Diagnostics and therapeutics for diseases associated with neuromedin u2 receptor (nmu2) |
| 03/02/2005 | EP1509769A2 Method of screening groups of radioactive molecules and applications thereof |
| 03/02/2005 | EP1509618A2 Autoimmune conditions and nadph oxidase defects |
| 03/02/2005 | EP1509617A2 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
| 03/02/2005 | EP1509541A2 Novel recombinant anticoagulant proteins |
| 03/02/2005 | EP1509532A1 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 03/02/2005 | EP1509526A2 Imidazo(1,2-a)pyrazin-8-ylamines, method of making, and method of use thereof |
| 03/02/2005 | EP1509524A1 Xanthine phosphodiesterase v inhibitor polymorphs |
| 03/02/2005 | EP1509522A1 1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands |
| 03/02/2005 | EP1509520A1 Use of benzo(c)quinolizinium derivatives for the treatment of diseases that are linked to smooth muscle cell constriction |
| 03/02/2005 | EP1509516A1 Inhibitors of the gpib -vwf interaction, their preparation and use |
| 03/02/2005 | EP1509509A1 Glucagon antagonists/inverse agonists |
| 03/02/2005 | EP1509506A1 Pyridazine derivatives |
| 03/02/2005 | EP1509505A2 SMALL MOLECULE MODULATORS OF THE 5−HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO |
| 03/02/2005 | EP1509501A1 1-(aminoalkyl)-3-sulfonylindole and -indazole derivatives as 5-hydroxytryptamine-6 ligands |
| 03/02/2005 | EP1509498A1 Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilization as medicament or diagnostic agent and medicament containing same |
| 03/02/2005 | EP1509495A1 Anilino liver x-receptor modulators |
| 03/02/2005 | EP1509489A1 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
| 03/02/2005 | EP1509251A2 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 03/02/2005 | EP1509249A2 Inclusion complexes of rosiglitazone |
| 03/02/2005 | EP1509248A1 Combination of angiotensin ii receptor blocker and beta-blocker for secondary prevention of myocardial infarction |
| 03/02/2005 | EP1509237A2 Methods of treating angiogenesis, tumor growth, and metastasis |
| 03/02/2005 | EP1509233A1 Liquid formulation of decitabine and use of the same |
| 03/02/2005 | EP1509228A1 Derivatives of 2-(1-benzyl-1h-pyrazolo (3, 4-b)pyridine-3yl) -5-(4-pyridinyl)-4-pyrimidine amine and the use thereof as guanylate cyclase stimulators |
| 03/02/2005 | EP1509219A1 Methods and compositions for the treatment of graft failure |
| 03/02/2005 | EP1509213A2 Acetamides and benzamides that are useful in treating sexual dysfunction |
| 03/02/2005 | EP1509202A1 Novel high viscosity embolizing compositions comprising prepolymers |
| 03/02/2005 | EP1509188A2 Compounds active at the glucocorticoid receptor ii |
| 03/02/2005 | EP1244649B1 Cyclic amp-specific phosphodiesterase inhibitors |
| 03/02/2005 | EP1238979B1 Fused heterotricyclic compounds, process for preparing the compounds and drugs containing the same |
| 03/02/2005 | EP1180102B9 Mutual prodrugs of amlodipine and atorvastatin |
| 03/02/2005 | EP1129084B1 Thiazole derivatives as ppar gamma ligands |
| 03/02/2005 | EP1042279B1 Substituted beta-alanines |
| 03/02/2005 | EP1014976B1 Novel substituted imidazole compounds |
| 03/02/2005 | EP0948499B1 Heteroarylsulfonamide derivatives and pharmaceutical compositions containing them |
| 03/02/2005 | EP0910397B1 Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis |
| 03/02/2005 | EP0797591B1 A novel chemokine expressed in inflamed adenoid, its production and uses |
| 03/02/2005 | CN1589279A Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 03/02/2005 | CN1589273A The use of anti-histaminics for acute reduction of elevated intracranial pressure |
| 03/02/2005 | CN1589271A Fused heterocyclic succinimide compounds and analogs thereof as modulators of nuclear hormone receptor function |
| 03/02/2005 | CN1589270A Indole-2-formamide compounds as factor Xa inhibitors |
| 03/02/2005 | CN1589269A Heteroindanes: a new class of potent cannabimimetic ligands |
| 03/02/2005 | CN1589268A Substituted benzopyrans compounds as selective estrogen receptor-beta agonists |
| 03/02/2005 | CN1589261A Piperidine derivatives and their use as modulators of chemokine receptor activity (especially CCR5) |
| 03/02/2005 | CN1589260A Heterocyclic compounds and methods of use thereof |
| 03/02/2005 | CN1589258A Novel beta -phenyl- alpha -oxysubstituted propionic derivatives: process for their preparation and their use in the preparation of pharmaceutically important compounds |
| 03/02/2005 | CN1589154A Medicinal compositions containing angiotensin II receptor antagonist |
| 03/02/2005 | CN1589151A Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 03/02/2005 | CN1589148A Succinic acid salts of 5, 8, 14-triazatetracyclo'10.3.1.0 less than2, 11greater than.0 less than 4, 9 greater than-hexadeca-2(11), 3, 5, 7, 9-pentaene and pharmaceutical compositions thereof |
| 03/02/2005 | CN1589146A Benzothiazole derivatives as adenosine receptor ligands |
| 03/02/2005 | CN1589145A αv整联蛋白受体拮抗剂 αv integrin receptor antagonists |
| 03/02/2005 | CN1589137A Treatment of neurodegenerative and cardiovascular disorders |
| 03/02/2005 | CN1589135A Small molecule antagonists of BCL-2 family proteins |
| 03/02/2005 | CN1589098A Prevention and treatment of diseases associated with blood coagulation |
| 03/02/2005 | CN1587369A Buck-wheat flavone vinega soft capsule and preparing method |
| 03/02/2005 | CN1587270A Medicinal composition contaniing angiotensin invertase inhibitor and vitamin B |
| 03/02/2005 | CN1587269A Medicinal composition containing angiotensin II receptor antagonist and vitamin B |
| 03/02/2005 | CN1586615A Starfish and seaweed compound product and its preparing method |
| 03/02/2005 | CN1586613A Granular powder for treating angina pectoris and its quality control method |
| 03/02/2005 | CN1586607A Chinese medicine preparation for treating cardio-cerebral vascular disease and its preparing method |
| 03/02/2005 | CN1586597A Ginseng oral disintegration tablet and its preparing process |
| 03/02/2005 | CN1586593A Wild chrysanthemum oral disintegration tablet and its preparing method |
| 03/02/2005 | CN1586589A Ginseng stem and leaf total saponin oral disintegration tablet and its preparing method |
| 03/02/2005 | CN1586587A Qingkailing oral disintegration tablet and its preparing method |
| 03/02/2005 | CN1586562A Card-otonic heart protecting pill |
| 03/02/2005 | CN1586558A Blood pressure reducing pill for hypertension |
| 03/02/2005 | CN1586554A Coronary red sage root oral disintegration tablet and its preparing method |
| 03/02/2005 | CN1586553A Medicinal composition for treating cardiocerebral vascular disease and its preparing method |
| 03/02/2005 | CN1586551A Rye-red yeast vinegar soft capsule and its preparing method |
| 03/02/2005 | CN1586550A Process for preparing ginkgo leaf extract powder injection |
| 03/02/2005 | CN1586549A Process for preparing sodium chloride injection of ginkgo leaf extract |
| 03/02/2005 | CN1586548A Ginkgo leaf extract and its extracting method |
| 03/02/2005 | CN1586544A Medicinal wine and its producing method |
| 03/02/2005 | CN1586535A Liuweidihuang effervescent tablet and its preparing method |
| 03/02/2005 | CN1586534A Nao'an oral disintegration tablet and its preparing method |
| 03/02/2005 | CN1586516A Medicinal composition for treating cardiocerebral vasculr disease and its preparing method |
| 03/02/2005 | CN1586510A Rhodiola sacra capsule containing glucoside and its preparing method |
| 03/02/2005 | CN1586508A Method for preparing chuanxiong rhizome volatile beta-cyclic dextrin clathrate compound by colloid mill |
| 03/02/2005 | CN1586502A Process for preparing compound coemzyme medicine and its compound coemzyme medicine and clinical use |
| 03/02/2005 | CN1586493A Dioscin oral disintegration tablet and its preparing method |
| 03/02/2005 | CN1586492A Medicinal composition containing danshensu, total ara-saponin and camphol and its preparation and use |
| 03/02/2005 | CN1586491A Medicinal composition containing salvianolic acid B, total ara-saponin and camphol and its preparation and use |
| 03/02/2005 | CN1586484A Dipyridamole soft capsule preparation and its preparing method |
| 03/02/2005 | CN1586473A Daphnetic soft capsule and its preparing method |
| 03/02/2005 | CN1586467A Troxerutin powder injection |
| 03/02/2005 | CN1191266C Compositions for treating inflammatory response |
| 03/02/2005 | CN1191254C Fused pyrrole compounds, pharmaceutical composition containing the same, and the use thereof |
| 03/02/2005 | CN1191251C Intermediate for preparing cyclopentane formamide compound and its preparation method |
| 03/02/2005 | CN1191241C Pyridazinyl phenyl hydrazones useful against congestive heart failure |
| 03/02/2005 | CN1191240C Nitrogen monoxide synthase inhibitor, its preparation method and application |
| 03/02/2005 | CN1191060C Topical compositions for prostaglandin El delivery |